Annamaria Quaranta
Brindisi, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Journal: Breast (Edinburgh, Scotland)
Published: January 06, 2024
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).
Journal: Breast (Edinburgh, Scotland)
Published: February 09, 2020
Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
Journal: Future oncology (London, England)
Published: October 04, 2019
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment.
Journal: Breast (Edinburgh, Scotland)
Published: August 07, 2016
Panitumumab after progression on cetuximab in KRAS wild-type metastatic colorectal cancer patients: a single institution experience.
Journal: Tumori
Published: April 22, 2015
BMI variation increases recurrence risk in women with early-stage breast cancer.
Journal: Future oncology (London, England)
Published: December 20, 2014
Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer.
Journal: Critical reviews in oncology/hematology
Published: May 26, 2014
Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: where are we now and where are we going?
Journal: Critical reviews in oncology/hematology
Published: November 25, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026